Tekla Capital Management LLC Karyopharm Therapeutics Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$9.85 - $17.69 $647,568 - $1.16 Million
-65,743 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$14.14 - $19.71 $929,606 - $1.3 Million
65,743 New
65,743 $960,000
Q1 2018

May 14, 2018
SELL
$9.92 - $17.25 $198 - $345
-20 Closed
0 $0
Q4 2017

Feb 14, 2018
SELL
$9.15 - $11.99 $6.92 Million - $9.07 Million
-756,659 Reduced 100.0%
20 $0
Q2 2017

Aug 14, 2017
BUY
N/A
756,679
756,679 $6.85 Million

Others Institutions Holding KPTI

# of Institutions
94
Shares Held
59.6M
Call Options Held
547K
Put Options Held
67K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $465M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email